---
layout: page
title: Research Achievements
lang: en
permalink: /en/achievements.html
---

### 📚**Peer-Reviewed Journal Articles**

1.	**○Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyama Otani, and Yoshihiro Yamanishi.  
Therapeutic target prediction for orphan diseases integrating genome-wide and transcriptome-wide association studies.  
Nat Commun., 16, 3355. https://doi.org/10.1038/s41467-025-58464-4 (2025.4.18)

2.	**○Satoko Namba**, Chen Li, Noriko Otani, and Yoshihiro Yamanishi.
   SSL-VQ: Vector-quantized variational autoencoders for semi-supervised prediction of therapeutic targets across diverse diseases.   Bioinformatics, 41(2), btaf039, https://doi.org/10.1093/bioinformatics/btaf039 (2025.1.28)

3.	Midori Iida, ..., **○Satoko Namba**, et al.
   A network-based trans-omics approach for predicting synergistic drug combinations.
  	Communications medicine, 4, 154. https://doi.org/10.1038/s43856-024-00571-2. (2024/7/29) 

4.	Hanako Yoshimura, ..., **○Satoko Namba**, et al.
   Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology.
  	The Journal of allergy and clinical immunology, 153(5), 1268-1281. https://doi.org/10.1016/j.jaci.2023.12.030. (4/4/2024)

5.	**○Satoko Namba**, Michio Iwata, & Yoshihiro Yamanishi.
   From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures.
  	Bioinformatics (Oxford, England), 38(Suppl 1), i68–i76. https://doi.org/10.1093/bioinformatics/btac240. (6/27/2022)

---

### 📕**Review Articles / Professional Magazines**

1.	**Satoko Namba**. 
“Conference & Workshop: The Future of Life Science Unveiled by AI—1st Asia & Paciﬁc Bioinformatics Joint Conference”,  
Experimental Medicine (Special Issue: “Synthetic Biology of Multicellular Systems / Getting Started with Bioinformatics via Conda”),   Vol.43, No.6, pp. 957–960. Yodosha, March 2025. ISBN 978-4-7581-2590-1. (in Japanese)

2. **Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“Therapeutic Target Prediction Using Genetic Perturbation-Response Omics Data: Cross-Disease Target Repositioning.”  
Experimental Medicine (Supplement: “Statistical Genetics in the Post-GWAS Era: A Systems View of Human Disease via Omics and Machine Learning”),  
Vol. 41, No. 7, pp. 181–187, Yodosha, April 2023. ISBN 978-4-7581-0410-4. (in Japanese)


---

### 🏆**Honors / Awards**

1. **Satoko Namba**.  
『The 130th Annual Meeting of the Japanese Association of Anatomists (JAA)・The 102nd Annual Meeting of the Physiological Society of Japan (PSJ)・The 98th Annual Meeting of the Japanese Pharmacological Society (JPS)』,  
Young Investigator Award, 2025.3.18.

2.	**Satoko Namba**.  
『Informatics in Biology, Medicine and Pharmacology 2023』,  
Outstanding Poster Award, 2023.9.7.

3.	**Satoko Namba**, et al.  
『14th Annual Meeting of the Young Researchers Association for Bioinformatics and Life Science』,  
Best NGS awards, 2022.9.11.

4.	**Satoko Namba**.  
『The Chem-Bio Informatics Society CBI Annual Meeting 2021』,  
Excellent Presentation Awards, 2021.10.27.

5.	**Satoko Namba**.  
『Informatics in Biology, Medicine and Pharmacology 2021』,  
Outstanding Poster Award, 2021.9.27.


---

### 💰**Grants / Fellowships**

1.	**Satoko Namba**.  
Grant-in-Aid for JSPS Fellows, 25KJ0159 (2025.4~2028.3)  
(Acceptance rate: 23.9%).

2.	**○Satoko Namba**,  
ISMB2022 Travel Fellowship, $1,000  
(Acceptance rate: 47/155)

3.	**Satoko Namba**,  
Grant-in-Aid for JSPS Fellows, 22KJ2494 (2022.4~2025.3)  
(Acceptance rate: 18.5%).


---

### 🗣️**Invited Talks**

1.	**Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“Target repositioning: predicting therapeutic targets using genetically perturbed transcriptome.”  
『5th CBI Young Researchers Symposium』, Online, 2022.6.3.


---

### 🌐**Oral Presentations at International Conferences [Peer-reviewed]**

1.	**○Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyama Otani, and Yoshihiro Yamanishi.  
“TRESOR: a disease signature integrating GWAS and TWAS  for therapeutic target discovery in rare diseases.”  
『The 33rd International Conference on Intelligent Systems for Molecular Biology (ISMB2025)』,  
Abstract Talk, Liverpool in UK, 2025.7.20–24.  

2.	**○Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“Target repositioning to predict therapeutic target proteins using genetically perturbed transcriptome data”.  
『The 31st International Conference on Intelligent Systems for Molecular Biology (ISMB2023)』,  
Online short talk, 2023年7月19日.

2.	**○Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures”.  
『The 30th International Conference on Intelligent Systems for Molecular Biology (ISMB2022)』,  
**Proceedings**, Madison in US, 2022年7月12日 (2022.7.10~2022.7.14).

---

### 🌐**Poster Presentations at International Conferences [Peer-reviewed]**

1.	**○Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“A trans-disease approach for predicting therapeutic target proteins using large-scale omics data”.  
『1st Asia & Pacific Bioinformatics Joint Conference (APBJC2024)』,  
Okinawa in Japan, 2024年10月24日 (2024.10.22~2024.10.25).

2.	Midori Iida, ..., **○Satoko Namba**, et al.  
“A Computational Method for Predicting Synergistic Drug Combinations Using Network Propagation and Trans-Omics Analysis”.  
『1st Asia & Pacific Bioinformatics Joint Conference (APBJC2024)』,  
Okinawa in Japan, 2024年10月23日 (2024.10.22~2024.10.25).  

3.	**○Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“A trans-disease approach for omics-based prediction of therapeutic target proteins”.  
『The 32nd International Conference on Intelligent Systems for Molecular Biology (ISMB2024)』,  
Montréal in Canada, 2024年7月15日 (2024.7.12~2024.7.16).  

4.	**○Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“Target repositioning to predict therapeutic target proteins using genetically perturbed transcriptome data”.  
『The 31st International Conference on Intelligent Systems for Molecular Biology (ISMB2023)』,  
Lyon in France, 2023年7月24日 (2023.7.23~2023.7.27).

---

### 🏯**Oral Presentations at Domestic Conferences [Peer-reviewed]**

1. **Satoko Namba**, Chen Li, Noriko Otani, and Yoshihiro Yamanishi.  
“Predicting therapeutic target molecules for rare diseases based on deep learning and genetically perturbed transcriptome.”  
『The 145th Annual Meeting of the Pharmaceutical Society of Japan』, Fukuoka, 2025.3.28 (2025.3.26~2025.3.29).

2. Shuto Yoshimoto, … **Satoko Namba**, et al.  
“In silico prediction of new therapeutic targets and drugs for schizophrenia.”  
『The 145th Annual Meeting of the Pharmaceutical Society of Japan』,  
Fukuoka, 2025.3.28 (2025.3.26~2025.3.29).

3. **Satoko Namba**, Chen Li, Noriko Otani, and Yoshihiro Yamanishi.  
“Prediction of therapeutic target molecules for rare diseases using gene perturbation transcriptome and semi-supervised deep learning.” 『The 130th Annual Meeting of the Japanese Association of Anatomists (JAA)・The 102nd Annual Meeting of the Physiological Society of Japan (PSJ)・The 98th Annual Meeting of the Japanese Pharmacological Society (JPS)』,  
Chiba, 2025.3.18 (2025.3.17~2025.3.19).

4. **Satoko Namba**, Chen Li, Noriko Otani, and Yoshihiro Yamanishi.  
“Prediction of Therapeutic Target Molecules Using Machine Learning and Its Application to Rare Diseases.”  
『10th CBI Society Symposium on Personalized Medicine』, Gifu, 2024.2.27.

5. **Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Otani and Yoshihiro Yamanishi.  
“Therapeutic target prediction for rare diseases integrating GWAS and TWAS data”.  
『Informatics in Biology, Medicine and Pharmacology 2023』, Chiba, 2023.9.7 (2023.9.7~2023.9.9).

6. Midori Iida, … **Satoko Namba**, et al.  
“Developing a network-based combination therapy approach for complex diseases”.  
『The Chem-Bio Informatics Society CBI Annual Meeting 2022』,  
Tokyo, 2022.10.25 (2022.10.25~2022.10.27).

7.	**Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“Target repositioning: predicting therapeutic targets using genetically perturbed transcriptome.”  
『Informatics in Biology, Medicine and Pharmacology 2022』,  
Osaka, 2022.9.14 (2022.9.13~2022.9.15).

8. **Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“Target repositioning: predicting therapeutic targets using genetically perturbed transcriptome.”  
『14th Annual Meeting of the Young Researchers Association for Bioinformatics and Life Science』,  
Online, (2022.9.10~2022.9.11).

9. **Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“From drug repositioning to target repositioning: omics-based prediction of therapeutic targets for a variety of diseases.”  
『The Chem-Bio Informatics Society CBI Annual Meeting 2021』,  
online, 10/26-28, 2021.

10. **Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“Proposal for target repositioning by transcriptomic signatures.”  
『13rd Annual Meeting of the Young Researchers Association for Bioinformatics and Life Science』,  
online, 10/22-24, 2021.

11. **Satoko Namba**, Michio Iwata, Midori Iida, and Yoshihiro Yamanishi.  
“Predicting therapeutic targets and drugs by genetically perturbed transcriptome signatures.”  
『12nd Annual Meeting of the Young Researchers Association for Bioinformatics and Life Science』,  
online, 8/27-28, 2020.

12. **Satoko Namba** and Hiroyuki Kubota.  
“Comparison of blood insulin level in diabetic and healthy rats.”  
『Association of Young Scientists for Mathematical Biology the 2rd Meeting』,  
Kanagawa, 8/29-31, 2019.

13. **Satoko Namba** and Hiroyuki Kubota.  
“Comparison of blood insulin level in diabetic and healthy rats.”  
『Toyota Physical and Chemical Research Institute Specially Promoted Research Program Summer Training Camp』,  
Okinawa, 8/17-19, 2019.


---

### 🏯**Oral Presentations at Domestic Conferences [Non-peer-reviewed]**

1.	**○難波里子**, 李晨, 大谷則子, 山西芳裕.  
「機械学習による治療標的分子の予測と希少疾患への応用」,  
『第10回CBI学会 個別化医療研究会』, 岐阜, 2024年2月27日.  

2.	**○難波里子**, 岩田通夫, 山西芳裕.  
「ターゲットリポジショニング：遺伝子摂動応答トランスクリプトームを用いた治療標的予測」,  
『生命情報科学若手の会の第14回研究会』, オンライン, 2022年9月10-11日.  

3.	**○難波里子**, 岩田通夫, 山西芳裕.  
「遺伝子発現データを用いたターゲットリポジショニングの提案」,  
『生命情報科学若手の会の第13回研究会』, オンライン, 2021年10月22-24日.

4.	**○難波里子**, 岩田通夫, 飯田緑, 山西芳裕.  
「摂動応答トランスクリプトームを用いた創薬標的分子と治療薬の探索」,  
『生命情報科学若手の会の第12回研究会』, オンライン, 2020年8月27-28日.

5.	**○難波里子**, 久保田浩行.  
「糖尿病ラットと健常ラットにおける血中インスリン濃度変化の比較」,  
『第二回数理生物学夏の学校2019』, 神奈川, 2019年8月29-31日.

7.	**○難波里子**, 久保田浩行.  
「糖尿病ラットと健常ラットにおける血中インスリン濃度変化の比較」,  
『豊田理化学研究所特定課題　夏合宿』, 沖縄, 2019年8月17-19日.

---

### 🏯**Poster Presentations at Domestic Conferences**

1.	阪口双葉、田中未来、**○難波里子**、上條陽平、庄司竜麻、菊池紀広、山西芳裕.  
「抗老化効果を持つ化合物の化学的特徴や作用機序の情報解析」,  
『日本薬学会第145回』一般ポスター発表, 福岡, 2025年3月27日（2025.3.26~2025.3.29）.

2.	阪口双葉、田中未来、**○難波里子**、上條陽平、庄司竜麻、菊池紀広、山西芳裕.  
「抗老化リプログラミングを誘導する低分子化合物の解析と予測」,  
『第130回 日本解剖学会／第102回 日本生理学会／第98回 日本薬理学会合同大会』  
一般ポスター発表, 千葉, 2025年3月18日（2025.3.17~2025.3.19）.

3.	吉本修人, 亀淵由乃, **○難波里子**, 山西芳裕, 古屋茂樹, 濱野桃子.  
「統合失調症様モデルマウスに対する新規治療標的と新薬の予測」,  
『第61回化学関連支部合同九州大会』, 福岡, 2024年6月29日.

4.	亀淵由乃, **○難波里子**, 関谷 拓海, 大谷 則子, 岩田 通夫, 山西 芳裕.  
「機械学習による薬剤標的分子予測と薬剤組み合わせ効果の検討」,  
『日本薬学会第144年会』, 神奈川, 2024年3月30 (2024.3.28~2024.3.31).

5.	亀淵由乃, **○難波里子**, 関谷 拓海, 大谷 則子, 岩田 通夫, 山西 芳裕.  
「シナジー効果を高める薬物の組み合わせを予測する情報技術の開発」,  
『第97回日本薬理学会年会』, 神奈川, 2023年12月15（2023.12.14~2023.12.16）.

6.	**○Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Otani, and Yoshihiro Yamanishi.  
“Therapeutic target prediction for rare diseases integrating GWAS and TWAS data”.  
『第12回生命医薬情報学連合大会』ポスター発表, 千葉, 2023年9月7日 (2023.9.7~2023.9.9).

7.	**○Satoko Namba**, Michio Iwata and Yoshihiro Yamanishi.  
「ターゲットリポジショニング：遺伝子摂動応答トランスクリプトームを用いた創薬標的予測」,  
『第10回生命医薬情報学連合大会』, オンライン, 2021年9月27日 (2021.9.27〜2021.9.29).

8.	**○難波里子**, 岩田通夫, 飯田緑, 山西芳裕.  
「摂動応答トランスクリプトームを用いた創薬標的分子と治療薬の探索」,  
『第9回生命医薬情報学連合大会』, オンライン, 2020年9月1-3日.

9.	**○Satoko Namba**, Katsuya Ogata, and Shozo Tobimatsu.  
"Frequency dependent effect of iTBS-tACS. English Poster Presentation of Kyushu University School of Medicine"",  
福岡, 2018年11月24日.

---

### 📰**Media Coverage**

1.	**○Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyam Otani, and Yoshihiro Yamanishi.  
“Development of AI to predict therapeutic target molecules for rare diseases — integrating genome and transcriptome data for novel therapies”,  
Nagoya University Research News Press Release, April 21, 2024.  
[web page](https://www.nagoya-u.ac.jp/researchinfo/result/2025/04/ai-103.html)

2.	**○Satoko Namba**, Michio Iwata, Shin-Ichi Nureki, Noriko Yuyam Otani, and Yoshihiro Yamanishi.  
“Development of AI to predict therapeutic target molecules for rare diseases — integrating genome and transcriptome data for novel therapies”,  
research_er.com, April 21, 2024.  
[web page](https://research-er.jp/articles/view/143717)

3.	**○Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.   
“Conference Report: ISMB2022”,  
Japanese Society for Bioinformatics (JSBI) Newsletter No. 42, January 31, 2023.  
[web page](https://www.jsbi.org/media/files/_u/topic/file/nl42.pdf)

4.	**○Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“AI accurately predicts therapeutic targets from big data of biomolecules and diseases”  
Chem-Station Spotlight Research No. 408, Japan’s largest chemistry portal site, August 16, 2022.  
[web page](https://www.chem-station.com/blog/2022/08/drtr.html#google_vignette)  

5.	**○Satoko Namba**, Michio Iwata, and Yoshihiro Yamanishi.  
“AI accurately predicts therapeutic targets from big data of biomolecules and diseases”  
Kyushu Institute of Technology Press Release, July 4, 2022.   
[web page](https://www.kyutech.ac.jp/whats-new/press/entry-9220.html)


<div style="margin-top: 20px;">
  <a href="../achievements.html">
    [日本語版はこちら / Japanese version]
  </a>
</div>
